Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Jorge Garcia, MD

Jorge Garcia, MD

  • Division Chief, Solid Tumor Oncology, UH Cleveland Medical Center
  • George and Edith Richman Distinguished Scientist Chair, UH Cleveland Medical Center
  • Director, GU Oncology Research Program, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Specialty: Hematology and Oncology, Medical Oncology
  • Location:
    UH Seidman Cancer Center
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Jorge Garcia, MD

Expertise

  • Clinical Research
  • Experimental Therapeutics
  • GU Medical Oncology

Certifications & Memberships

  • Medical Oncology - American Board of Internal Medicine

Education

Fellowship | Urologic Oncology
Urologic Oncology - UCSF Medical Center (2003 - 2004)

Fellowship | Hematology/Oncology
Hematology/Oncology - UCSF Medical Center (2001 - 2003)

Residency | Internal Medicine
Internal Medicine - Albert Einstein College Of Medicine Of Yeshiva University (1998 - 2001)

Research Fellowship | Cancer Biology
Cancer Biology - Harvard Medical School (1995 - 1998)

Medical Education
Escuela Colombiana De Medicina (1994)

About

Jorge A. Garcia, MD, FACP, is a Professor of Medicine and Urology at Case Western Reserve University in Cleveland, Ohio. He is the George and Edith Richman Distinguished Scientist Chair and the current chair of the Solid Tumor Oncology Division at University Hospitals Seidman Cancer Center/Case Comprehensive Cancer Center. Dr. Garcia’s work focuses on genitourinary malignancies. He is the current director of the GU Medical Oncology clinical and research programs at University Hospitals Seidman Cancer Center.

Dr. Garcia earned his medical degree at the Colombian School of Medicine in Bogota, Colombia (South America). After completing a Cancer Biology Fellowship at Harvard Medical School, Dr. Garcia completed his training in Internal Medicine at the Albert Einstein College of Medicine in New York. Subsequently, Dr. Garcia completed his fellowship in hematology and medical oncology and urologic oncology at the University of California San Francisco.

Certified in Medical Oncology and Internal Medicine by the American Board of Internal Medicine, Dr. Garcia’s primary research interests have been in prostate, kidney and bladder cancer, with special focus on developmental therapeutics, immune oncology and targeted therapy. Dr. Garcia has authored more than 250 manuscripts and book chapters and his research has been published in peer-reviewed journals including New England Journal of Medicine, Clinical Cancer Research, Journal of Clinical Oncology, Lancet, JAMA, Cancer, Journal of the National Cancer Institute, Journal of Urology and BJU International, among others. He has also served on numerous editorial boards as editor and reviewer.

Dr. Garcia came to UH Seidman Cancer Center after spending 16 years at the Cleveland Clinic, where he served as the Kerscher Family Chair for Prostate Cancer Research and a staff physician in the medical oncology and urology departments. While at the Cleveland Clinic, Dr. Garcia also served as the chair of the Case Comprehensive Cancer Center PRMC and more recently as the director of the cancer center’s clinical research office.

Dr. Garcia is a member of several professional societies, including the American College of Physicians, Association of Cancer Research, American Society of Clinical Oncology and the American Medical Association. Dr. Garcia is a Fellow of the American College of Physicians and has served in the past as a relevance reviewer for the American Board of Internal Medicine. Dr. Garcia has been listed among the best doctors in Cleveland and the U.S. every year since 2009.

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Jorge Garcia did not disclose any Outside Relationships with Industry.